Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

24/31 May 2014, Vol 292, 7811/7812

Editorial

An ongoing test: Making NHS care acceptable to patients

NHS care that would never pass the “friends and family test” continues to emerge. That the Princess of Wales Hospital was in September 2013 the first institution in Wales to implement the test — an NHS England creation — is remarkable given that it is one of two hospitals in South Wales that have since been shown to be under-delivering.

Feature

The Pharmaceutical Journal, 24/31 May 2014, Vol 292, 7811/7812

Darzi Fellowship accepts pharmacy-led project to improve care of AF patientsSubscription

By

Patients with atrial fibrillation who take new oral anticoagulants to reduce their risk of stroke need a smooth transition of care from hospital to community, Asha Fowells finds

Comment

EU Flag

What does the EU have to do with me?Subscription

By

The RPS representative on the Pharmaceutical Group of the European Union, Sid Dajani, takes a look at the areas of EU policy that can affect UK pharmacy practice

Protozoa and blood cells

Time to act: pharmacists must be prepared for environmental changesSubscription

By , , , ,

How will the pharmacist’s role evolve as the world’s climate changes? Iain Davidson and colleagues describe the impact of the profession on the planet — and vice versa

CPD article

Ehlers-Danlos

Ever heard of Ehlers-Danlos syndrome?Subscription

By

One in 5,000 people has Ehlers-Danlos syndrome — at least twice the number as have sickle cell anaemia, phenylketonuria or haemophilia A. Learn more about it here

Books and arts

Generic drug product development

Useful text for industry and regulatory professionalsSubscription

By

This updated edition of ‘Generic drug product development: solid oral dosage forms’ is the latest publication in the series ‘Drugs and pharmaceutical sciences’, a range that will be recognisable to many pharmacists and researchers by its distinctive red covers.

Patient-centered medicine: transforming the clinical method

Patient-centred medicine from various perspectivesSubscription

By

Patient-centered medicine: transforming the clinical method’ 3rd edition. By Moira Stewart, Judith Belle Brown, W. Wayne Weston, Ian R. McWhinney, Carol L. McWilliam and Thomas R. Freeman. Pp xv+426 Price

CAREER

Tutoring (Andrey Kiselev/Dreamstime.com)

Take full advantage of having a tutorSubscription

By

Newly qualified hospital pharmacist Lauren Rose describes what you can expect from being tutored and shares some tips for making the most of the experience

The Pharmaceutical Journal

24/31 May 2014, Vol 292, 7811/7812

Cover Story:

Atrial fibrillation (AF) is the most common heart rhythm abnormality, affecting some 800,000 people in the UK. Compared with the statistics for a disease like diabetes, which is thought to affect nearly three million people, this number may not seem terribly significant. However, for further comparison, over 331,000 people in the UK were diagnosed with cancer in 2011, which is over 900 cases a day. With AF coming in at more than twice that incidence, and affecting around 10% of people aged over 75 years at a time when the population is ageing, the scale of the problem becomes apparent…

Read more…

The Pharmaceutical Journal

View previous issue

YOUR RPS

john-cromarty-2013

For whom the “Bells” tollSubscription

By

Chairman of the Scottish Pharmacy Board John Cromarty urges pharmacists to learn from the past

EU Flag

What does the EU have to do with me?Subscription

By

The RPS representative on the Pharmaceutical Group of the European Union, Sid Dajani, takes a look at the areas of EU policy that can affect UK pharmacy practice